Illumina Inc (ILMN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ILMN | RPRX | INCY | ||
| Company | Illumina Inc | Royalty Pharma Plc Cl A | Incyte Corp | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 145.30 | 39.72 | 105.55 | ||
| High | 145.42 | 39.78 | 108.58 | ||
| Low | 141.37 | 39.35 | 104.83 | ||
| Latest | 141.65 | 39.55 | 106.21 | ||
| Change | -3.65 | -0.17 | +0.97 | ||
| % Change | -2.51% | -0.43% | +0.92% | ||
| Volume | 1,901,800 | 1,988,000 | 1,696,200 | ||
| 20-Day Average Volume | 1,704,660 | 3,312,685 | 2,101,520 | ||
| Previous Close | 145.30 | 39.72 | 105.24 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 139.55 | 39.58 | 102.98 | ||
| 20-Day Raw Stochastic | 54.61% | 38.57% | 60.21% | ||
| 20-Day Relative Strength | 57.28 | 51.95 | 57.17 | ||
| Weighted Alpha | +24.63 | +27.63 | +59.02 | ||
| Today's Opinion | 100% Buy | 88% Buy | 100% Buy | ||
| Previous Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 80% Buy | 72% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.41% since 01/09/26 | -1.54% since 01/09/26 | -0.62% since 01/09/26 | ||
| Low | 140.19 on 01/14/26 | 39.35 on 01/16/26 | 102.68 on 01/13/26 | ||
| High | 151.00 on 01/13/26 | 40.58 on 01/14/26 | 108.58 on 01/16/26 | ||
| 1-Month | |||||
| %Chg | +7.67% since 12/16/25 | +3.05% since 12/16/25 | +9.46% since 12/16/25 | ||
| Low | 129.29 on 12/17/25 | 38.20 on 12/19/25 | 97.01 on 12/18/25 | ||
| High | 151.34 on 01/07/26 | 41.70 on 01/08/26 | 112.29 on 01/07/26 | ||
| 3-Month | |||||
| %Chg | +47.69% since 10/16/25 | +8.83% since 10/16/25 | +21.65% since 10/16/25 | ||
| Low | 94.00 on 10/30/25 | 35.92 on 10/28/25 | 84.02 on 10/28/25 | ||
| High | 151.34 on 01/07/26 | 41.70 on 01/08/26 | 112.29 on 01/07/26 | ||
| 6-Month | |||||
| %Chg | +46.09% since 07/16/25 | +11.10% since 07/16/25 | +53.42% since 07/16/25 | ||
| Low | 88.00 on 10/14/25 | 34.08 on 09/08/25 | 67.17 on 07/21/25 | ||
| High | 151.34 on 01/07/26 | 41.70 on 01/08/26 | 112.29 on 01/07/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 21,644,120 | 22,829,762 | 20,851,464 | ||
| Shares Outstanding, K | 152,800 | 577,238 | 196,323 | ||
| Annual Sales | 4,372,000,000 | 2,263,580,000 | 4,241,220,000 | ||
| Annual Net Income | -1,223,000,000 | 858,980,000 | 32,610,000 | ||
| Last Quarter Sales | 1,084,000,000 | 609,290,000 | 1,365,980,000 | ||
| Last Quarter Net Income | 150,000,000 | 288,220,000 | 424,170,000 | ||
| 60-Month Beta | 1.41 | 0.43 | 0.82 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.34 on 10/30/25 | 1.17 on 11/05/25 | 2.26 on 10/28/25 | ||
| Latest Earnings Date | 02/05/26 | 02/10/26 | 02/09/26 | ||
| Most Recent Dividend | N/A | 0.220 on 11/14/25 | N/A | ||
| Next Ex-Dividends Date | N/A | 02/20/26 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 33.33 | 8.79 | 19.78 | ||